A sample of 35 pyrazinamide (PZA)-resistant and 30 PZA-susceptible clinical isolates recovered from Beijing and Taiyuan City, China were characterized by SSCP and sequence analysis for mutations in the pncA gene that encodes the Mycobacterium tuberculosis PZase. The purpose of this study was to understand the molecular basis and the characteristics of pncA gene mutations and its relation to PZA resistance in M. tuberculosis strains from China. Several mutations with base changes leading to amino acid substitutions were found in the PZAresistant isolates. No mutations were seen in the 243 PZA-susceptible isolates. Among the 35 PZA-resistant isolates, 32 isolates (91n4 %) had nucleotide substitutions, insertions and deletions that resulted in amino-acid substitution ; or frameshifts in some strains. Other previously uncharacterized mutations were found as follows : Asn118-Thr, CG insertion at position 501 ; CC insertion at nucleotide position 403 ; a 8 base-pair deletion at start codon ; Pro54-Thr ; AG insertion at 368 ; Tyr41-His, Ser88-stop, and A insertion at nucleotide position 301. IS6110 subtyping revealed that each strain was unique ; indicative of the epidemiologic independence of the isolates.
INTRODUCTION
The resurgence of tuberculosis coupled with the emergence of drug-resistant Mycobacterium tuberculosis strains seriously compromises our ability to control tuberculosis [1] . Multiple drug-resistant strains of M. tuberculosis defined as resistance to at least isoniazid and rifampin have stimulated a great deal of research aimed at understanding the molecular basis of drug resistance in M. tuberculosis. Such knowledge should eventually facilitate the rational design of new anti-tuberculosis drugs ; and the development of rapid tests for proper detection of drug resistance.
Pyrazinamide (PZA) ; a nicotinamide analogue, has been in use for almost 50 years as a first line drug to treat tuberculosis. PZA is bactericidal to semidormant mycobacteria and reduces the total tuberculosis treatment time when used in combination with isoniazid and rifampin [2] [3] [4] [5] [6] [7] [8] [9] . This has made PZA the third important drug in the list of modern therapy for tuberculosis. Although the exact biochemical basis of PZA activity in i o is not known, under acidic conditions it is thought that the bacterial enzyme pyrazinamidase (PZase) is required to convert PZA to pyrazinoic acid (POA) which is toxic to M. tuberculosis [1, 2, 10, 11] . The finding that PZA-resistant strains lose PZase activity and the hypothesis that PZase is required to convert PZA to POA intracellularly led to the recent cloning and characterization of the M. tuberculosis gene pncA that encodes PZase [2, 12] . DNA sequencing of PZAresistant clinical isolates indicated mutations in the pncA gene : These mutations are currently thought to confer resistance to PZA. However, the extent of geographical variation in pncA gene mutations deserves further studies.
The present study sought to understand the molecular basis and characteristics of PZA resistance and its relation to potential pncA gene mutations in M. tuberculosis clinical isolates from China. We analysed the DNA sequence of the pncA gene in samples of PZA-resistant and PZA-susceptible clinical isolates from Beijing and Taiyuan, China.
METHODS

Mycobacterium strains
Thirty-five PZA-resistant and 30 PZA-susceptible clinical isolates recovered from Beijing and Taiyuan City, China, over a 2-year period (1996-8) were used in this study. All patients were inhabitants of Beijing and Taiyuan City, and 33 of the patients had previously received anti-tuberculosis therapy. Treatment history was unknown for three patients. The initial anti-tuberculosis therapy included isoniazid, rifampin, and pyrazinamide. All isolates included in this study were obtained before this regimen was changed based on the respective drug susceptibility results. All strains were characterized for their IS6110 subtypes by an internationally standardized protocol [13] . All isolates were tested for PZA susceptibility with either the BACTEC radiorespiratory method at pH 6n0 [14, 15] or by the conventional proportion method with a PZA concentration of 25 µg\ml in 7H10 agar (pH 5n5) [16] . Susceptibility was defined as MIC of no more than 100 µg\ml of PZA. Most of the strains analysed in this study were highly resistant to PZA (MIC 500 µg\ml). Re-testing for PZA susceptibility of PZA-resistant strains without pncA mutations was performed by both the BACTEC method and the 7H10 agar medium method at pH (5n5). Genomic DNA was prepared according to a protocol generously provided by Dr J. D. A. Van Embden [17] . All genomic DNA extraction and drug susceptibility tests were carried out at the Shanxi Medical University, Taiyuan, China ; and then shipped to the University of Tsukuba, Ibaraki, Japan, for further molecular analyses. Mycobacterium culturing and DNA isolation were conducted in Biosafety level 3 laboratory.
PCR conditions
Three sets of primers were designed according to the Mycobacterium tuberculosis pncA sequence (558 bp) (GenBank accession number U59967) [12] (Table 1) . PCR was performed as described by Dr J. D. A. Van Embden [17] . The PCR conditions were 96 mC for 3 min, followed by 30 cycles of 96 mC for 1 min, 63 mC for 1 min and 72 mC for 2 min, with a final extension of 72 mC for 6 min.
SSCP analysis
SSCP was carried out as below ; Briefly, PCR products (0n5-1 µg of DNA) were mixed with 6 µl of denaturing reaction solution (Perkin-Elmer), the mixture was denatured by boiling for 10 min, and cooled on ice for 5 min. The single-strand PCR products were loaded onto a 10 % polyacrylamide gel. Electrophoresis was performed at 10 V\cm for 5 h at 10 mC. Single-strand bands were visualized by the ethidium bromide staining method.
Automated DNA sequencing of the pncA gene
The pncA genes were amplified by PCR using the conditions and primers described above. PCR products from isolates showing variant banding patterns in SSCP were cut from the gel and purified with the Geneclean kit (United State Biochemicals). The purified PCR products were directly sequenced using Genetic Analyzer (Perkin-Elmer, ABI PRISM AM 310). After termination dideoxy-cycle sequencing, the resulting data were assembled and edited using SeqEd v. 1.0.3 software (Applied Biosystems). The sequences were compared with published sequence of pncA from Genbank [12] . All mutations in the pncA structural gene were confirmed by re-sequencing.
RESULTS
All Mycobacterium tuberculosis complex clinical isolates studied had a C-T change at nucleotide 67 which has been identified as a sequence error by pncA gene mutations in China 
PCR-SSCP analysis
PCR-SSCP analysis was performed for the rapid detection of point mutations in the pncA gene. Selected PZA-resistant clinical isolates were used for the PCR-SSCP analysis. This process was rapid and very convenient (Fig. 1) .
pncA mutations in PZA-resistant M. tuberculosis clinical isolates
Results of the direct sequence analysis of pncA gene from different PZA-resistant isolates are shown in Table 2 . Among the 35 PZA-resistant clinical isolates, 32 isolates had mutations that included nucleotide substitutions (missense mutation), or insertions and deletions (nonsense mutation) leading to amino-acid substitutions in some cases ; or frameshifts with corresponding nonsense polypeptides in some strains. The mutations found were diverse and dispersed along the entire pncA gene. Most of the mutations (68n8%, 22\32) are point mutations causing aminoacid substitutions (Table 2 ). For instance isolate CBC01 had a C to A change at nucleotide position 425, and a resulting Thr142-Lys substitution ; CBC02 had A to C change at position 35, leading to an Asp12-Ala amino-acid substitution ; isolate CBC03 had A to C change at nucleotide position 353 and caused a Asn118-Thr amino-acid substitution. Isolate CBC07 had a C deletion mutation at nucleotide position 28 ; CCT03 had C deletion at 59 ; CCT08 had G deletion at 71, and CCT16 had a C deletion at 28. All deletion mutations caused amino acid frameshifts. CBM01 had CG insertion mutation at position 501 and CBM02 had CC insertion mutation at 403, leading to amino-acid frameshifts. Two isolates had a mutation that created a stop codon ; CBM06 had C-T change at nucleotide position 123, causing a change of Tyr41-stop. CCT19 had C to A change at 263, leading to a change of Ser88-stop. Two isolates had deletion mutations at start codon ; CCT02 had 8-bp deletion and CBM04 had 11-bp deletion. These mutations may weaken the promoter activity and thus decrease the level of PZase expression in such mutants. Overall, 26 types of mutations were found. However, a certain degree of conservation of pncA mutations were also observed at the following nucleotides : CCT09 isolates and CCT04 had the same mutation at codon Lys96-Asn ; CBC06, CCT11 had the same mutation of Val139-Ala ; and CBM03, CBC01 and CCT05 had the same mutation of Thr142-Lys. pncA gene mutations in China
Other previously uncharacterized mutations were also found, and includes the following changes : Asn118-Thr, CG insertion at position 501 ; CC insertion at 403 ; an 8 bp deletion at start codon ; Pro54-Thr ; AG insertion at 368 ; Tyr41-His, and Ser88-stop and A insertion at 301. Several other mutations previously identified by Hirano and colleagues were also found in our clinical isolates (Table 2 ) [18] . Three out of 35 PZA-resistant isolates did not contain any detectable pncA mutations (CBC05, CBC08 and CTT10). One of these isolates was actually susceptible to PZA ; while two of them were resistant to PZA upon re-testing by both methods [14] [15] [16] .
DISCUSSION
Recent studies have indicated that mutations in the M. tuberculosis pncA gene are associated with PZA resistance [12] . These studies have thus promoted a more thorough examination of sequence variations in this gene in order to identify genetically distinct susceptible and resistant organisms. In this study we found that 32 out of 35 PZA-resistant clinical M. tuberculosis isolates had mutations in the pncA gene. Unlike mutation in other M. tuberculosis genes such as rpoB and KatG genes, the spectrum of mutations in the pncA gene was very broad. A large number of distinct pncA gene mutations were associated with PZA resistance ; and the changes were distributed virtually throughout the entire length of the gene. Most of the pncA gene mutations had nucleotide substitutions resulting in single amino-acid replacements. This discovery extends the common observation that has emerged from studies of antimicrobial resistance M. tuberculosis [1] .
Our data also showed nucleotide deletion (18n8%; 6\32) and nucleotides insertion mutation (12n5%; 4\32). Changes resulting in frameshift mutations may be associated with PZA resistance. The results obtained in our study are supported by several published literatures [1, 12, 19] . Hirano and colleagues found a correlation of the development of PZA resistance with mutations in the pncA gene. The large number of distinct pncA gene mutations associated with PZA resistance supports the notion that enzymatic activity against PZA can be influenced by more than one molecular mechanism [1] .
Further studies are needed to assess the role of the specific mechanisms of the respective pncA gene mutations on PZA resistance, and the level of PZase activity alterable by the different mutations. The results of this study also indicate that regular survey of clinical isolates with a combination of PCR-SSCP analysis could help not only in epidemiological studies of M. tuberculosis outbreaks, but also in understanding the rate and trends in mutations ; in relation to PZA resistance over time. In this study we observed a possible association between single nucleotide changes leading to frameshift mutations and PZA resistance. Similar changes were found by Srinand and colleagues [1] ; the occurrence of these mutations could probably influence the survival of the organisms. For instance, in their study, Srinand and colleagues observed that deletions at nucleotide 70 conferred to the organism an ability to maintain viability in the total absence of PZase activity [1] .
Obviously, additional mechanisms of PZA have been known to exist. However, such mechanisms have not been fully elucidated. The most up-to-date study on alternate mechanisms was by Raynaud and colleagues in 1999 ; they showed that the uptake of PZA is required for the activation of the pro-drug. Also, an ATP-dependent transport system is probably involved in the uptake of PZA. Diffusion experiments by Raynaud and colleagues also showed that PZA diffusion through membrane bilayers was faster than glycerol in liposomes ; whereas the presence of ompATb, a porin-like protein of Mycobacterium tuberculosis in proteoliposomes slightly increased the diffusion of PZA. Their study also indicated that only naturally PZA-susceptible species exhibited both PZase activity and PZA uptake ; whilst no such correlation was observed in naturally resistant species [11] . Thus, a functional PZase and a PZA transport system are necessary for the susceptibility of Mycobacterium tuberculosis. Additionally, the lack of pncA gene mutations among the PZA-susceptible isolates is a clear indication of the utility of the methods applied in this study and elsewhere for differentiating susceptible and resistant clinical isolates [1, 12, 19] .
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